Loading the company…
Loading the company…
No clearances or recalls under the mapped product codes.
All companies · Product and company coverage
In 2025, Illuminoss Medical reported engagement with 282 surgeons and other clinicians in the states MedaRep covers, worth $130K in consulting, speaking, meals and travel for its device products, the most in Texas ($31K to 21). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Texas ($31K, 21 engaged), California ($24K, 35 engaged), Florida ($23K, 33 engaged), Colorado ($11K, 10 engaged), Washington ($5,796, 16 engaged).
In the last ten years FDA made 6 decisions for Illuminoss Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 0 procedure families, the most in 2020 (3). The latest was on 2024-01-19.
| IlluminOss Photodynamic Bone Stabilization System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Illuminoss Medical.